Technology areas: Biotechnology & Pharmaceuticals • Medical Devices & Mechanical Engineering
8 pending office actions • 8 art units • 8 examiners • 0 of 8 (0%) have an AI response strategy ready • 15 patents granted in the last 365 days
Taipei Medical University currently has 8 pending office actions within the Medical Devices & Mechanical Engineering technology area. These actions are handled by the same number of distinct examiners, showing a balanced ratio of pending matters to assigned personnel. This prosecution activity is spread across 8 distinct art units, which indicates that each application is being reviewed in a separate specialized environment. BECCIA, CHRISTOPHER J is the busiest examiner for the university, currently managing 1 busiest examiner pending action.
The university maintains a distributed prosecution profile across the examiners. The fact that multiple art units are involved suggests a variety of medical engineering innovations across different technical classifications. Because BECCIA, CHRISTOPHER J is the busiest examiner with only 1 busiest examiner pending action, the workload is spread across the personnel. This structure results in separate prosecution paths across the different units involved in the current portfolio. Practitioners should expect diverse examiner perspectives as the university navigates these distinct technical challenges within the medical engineering field.
Based on the USPTO statutory response window for each pending office action. 2 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 only | 1 (12%) |
| §101 + other | 1 (12%) |
| §103 only | 2 (25%) |
| §112 only | 1 (12%) |
| Multi-statute (no §101) | 3 (38%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| BECCIA, CHRISTOPHER J | 1 | 83.5% | +14.0% |
| AUDET, MAURY A | 1 | 50.1% | +23.9% |
| HILSMIER, HEIDI ANN | 1 | 53.8% | +65.9% |
| MOLOYE, TITILAYO | 1 | 62.3% | +48.3% |
| SCHACHERMEYER, SAMANTHA LYNN | 1 | 35.7% | +70.8% |
| SAFAIPOUR, BOBBAK | 1 | 86.1% | +10.8% |
| GEBREMICHAEL, BRUK A | 1 | 22.0% | +23.3% |
| NEWTON, CHAD A | 1 | 38.4% | +23.4% |
Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18398320 | EYE IMAGE CAPTURING AND PROCESSING DEVICE | SAFAIPOUR, BOBBAK | — |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 5 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18326004 | METHOD AND APPARATUS FOR PREDICTING PERSISTENT POSTCONCUSSIVE NEUROPSYCHIATRIC SYMPTOMS USING THALAMOCORTICAL COHERENCE | NEWTON, CHAD A | 75d |
| 18959657 | BIOCOMPATIBLE COMPOSITION, METHOD FOR PREPARING THE SAME, AND METHOD FOR TISSUE ADHESION | BECCIA, CHRISTOPHER J | — |
| 18746300 | Pharmaceutical Composition and Method for Treating Neurodegenerative Disorders Utilising the Pharmaceutical Composition | MOLOYE, TITILAYO | — |
| 18641154 | COMPOSITIONS AND METHODS FOR PREVENTING OR TREATING PRECOCIOUS PUBERTY | SCHACHERMEYER, SAMANTHA LYNN | — |
| 18467722 | METHOD, THE COMPUTING DEIVCE, AND THE NON-TRANSITORY COMPUTER-READABLE RECORDING MEDIUM FOR PROVIDING COGNITIVE TRAINING | GEBREMICHAEL, BRUK A | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18765430 | SYSTEM AND METHOD FOR MONITORING BLOOD PRESSURE | HILSMIER, HEIDI ANN | 8d overdue |
| 18326004 | METHOD AND APPARATUS FOR PREDICTING PERSISTENT POSTCONCUSSIVE NEUROPSYCHIATRIC SYMPTOMS USING THALAMOCORTICAL COHERENCE | NEWTON, CHAD A | 75d |
| 18959657 | BIOCOMPATIBLE COMPOSITION, METHOD FOR PREPARING THE SAME, AND METHOD FOR TISSUE ADHESION | BECCIA, CHRISTOPHER J | — |
| 18806827 | NOVEL PEPTIDE, USGAES THEREOF AND PHARMACEUTICAL COMPOSITION HAVING THE SAME | AUDET, MAURY A | — |
| 18746300 | Pharmaceutical Composition and Method for Treating Neurodegenerative Disorders Utilising the Pharmaceutical Composition | MOLOYE, TITILAYO | — |
| 18641154 | COMPOSITIONS AND METHODS FOR PREVENTING OR TREATING PRECOCIOUS PUBERTY | SCHACHERMEYER, SAMANTHA LYNN | — |
| 18398320 | EYE IMAGE CAPTURING AND PROCESSING DEVICE | SAFAIPOUR, BOBBAK | — |
| 18467722 | METHOD, THE COMPUTING DEIVCE, AND THE NON-TRANSITORY COMPUTER-READABLE RECORDING MEDIUM FOR PROVIDING COGNITIVE TRAINING | GEBREMICHAEL, BRUK A | — |
| Art Unit | Apps |
|---|---|
| 3775 | 1 |
| 1654 | 1 |
| 3796 | 1 |
| 1615 | 1 |
| 1693 | 1 |
| 2665 | 1 |
| 3715 | 1 |
| 3681 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18959657 | BIOCOMPATIBLE COMPOSITION, METHOD FOR PREPARING THE SAME, AND METHOD FOR TISSUE ADHESION | BECCIA, CHRISTOPHER J | 3775 | §102§103 | Non-Final OA | — | Pending | Nov 26, 2024 |
| 18806827 | NOVEL PEPTIDE, USGAES THEREOF AND PHARMACEUTICAL COMPOSITION HAVING THE SAME | AUDET, MAURY A | 1654 | §112 | Non-Final OA | — | Pending | Aug 16, 2024 |
| 18765430 | SYSTEM AND METHOD FOR MONITORING BLOOD PRESSURE | HILSMIER, HEIDI ANN | 3796 | §103 | Final Rejection | 8d overdue | Pending | Jul 08, 2024 |
| 18746300 | Pharmaceutical Composition and Method for Treating Neurodegenerative Disorders Utilising the Pharmaceutical Composition | MOLOYE, TITILAYO | 1615 | §102§103 | Non-Final OA | — | Pending | Jun 18, 2024 |
| 18641154 | COMPOSITIONS AND METHODS FOR PREVENTING OR TREATING PRECOCIOUS PUBERTY | SCHACHERMEYER, SAMANTHA LYNN | 1693 | §103§112 | Non-Final OA | — | Pending | Apr 19, 2024 |
| 18398320 | EYE IMAGE CAPTURING AND PROCESSING DEVICE | SAFAIPOUR, BOBBAK | 2665 | §103 | Non-Final OA | — | Pending | Dec 28, 2023 |
| 18467722 | METHOD, THE COMPUTING DEIVCE, AND THE NON-TRANSITORY COMPUTER-READABLE RECORDING MEDIUM FOR PROVIDING COGNITIVE TRAINING | GEBREMICHAEL, BRUK A | 3715 | §101§103§112 | Final Rejection | — | Pending | Sep 14, 2023 |
| 18326004 | METHOD AND APPARATUS FOR PREDICTING PERSISTENT POSTCONCUSSIVE NEUROPSYCHIATRIC SYMPTOMS USING THALAMOCORTICAL COHERENCE | NEWTON, CHAD A | 3681 | §101 | Final Rejection | 75d | Pending | May 31, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialTaipei Medical University has 8 pending office actions as of October 2026, spread across 8 art units and 8 examiners.
Christopher J Beccia has the most, with 1 of Taipei Medical University's pending office actions.
Mostly Medical Devices & Mechanical Engineering (USPTO Tech Center 3700), based on where its pending office actions are examined.
